Alicia Grande Net Worth & Insider Trades

Alicia Grande - VP, Catalyst Pharmaceuticals, Inc

As of November 23, 2022

What is Alicia Grande's Net Worth?

The current estimated net worth of Catalyst Pharmaceuticals, Inc's VP, Alicia Grande, is estimated to be about $12.23M . Alicia Grande owns about 27,442 units of Catalyst Pharmaceuticals, Inc common stock. In the last 15 years at Catalyst Pharmaceuticals, Inc, Alicia Grande has sold an estimated value of $9.32M worth.

What is Alicia Grande's Past Insider Trading?

Alicia Grande's largest purchase order was 170,000 units , worth over $530.4K on August 19, 2021. Alicia Grande's largest sale order was 150,000 units , worth over $2.08M on August 19, 2022. In total, Alicia Grande has made about 34 transactions over 15 years of their time at Catalyst Pharmaceuticals, Inc. Alicia Grande usually trades in December, with the busiest year in 2022. The most recent transaction was a sale order of 120,000 units , worth over $1.98M on November 23, 2022.

Alicia Grande

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Alicia Grande's' Mailing Address?

  • Mailing address is 220 Miracle Mile Suite 234 Coral Gables FL 33134 FL

Catalyst Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Patrick J. McEnany 2018 $524,236 $332,063 $ $3,461,504 $3,461,504 $ $3,461,504
Steven R. Miller, COO and CSO 2018 $427,441409,325 $188,600 $ $1,655,195 $1,655,195 $11,000 $1,655,195
Gary Ingenito, CM&RO 2018 $399,373 $194,810 $ $1,666,645 $1,666,645 $26,192 $1,666,645
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm

What are Catalyst Pharmaceuticals, Inc's Past Insider Trades?

Catalyst Pharmaceuticals, Inc's most recent insider trade came on November 23, 2022 by Alicia Grande who sold 120,000 units worth $1.98M . In the last 15 years, insiders at Catalyst Pharmaceuticals, Inc have sold an estimated value of $56.83M and bought an estimated value of $19.06M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Patrick J McEnany, President and CEO,  Charles B. O'Keeffe, Director,  and Philip H Coelho, Director .

CATALYST PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1